Steven Rosenberg, M.D., Ph.D.: The de... - Advanced Prostate...

Advanced Prostate Cancer

21,447 members26,867 posts

Steven Rosenberg, M.D., Ph.D.: The development of cancer immunotherapy and its promise for treating advanced cancers

Scout4answers profile image
4 Replies

“It's the balance of the aggressive immune reaction against the inhibitory molecules that can prevent that immune reaction that is the holy grail of trying to find effective treatments.” —Steven

Rosenbergpeterattiamd.com/stevenrose...

Written by
Scout4answers profile image
Scout4answers
To view profiles and participate in discussions please or .
Read more about...
4 Replies
KocoPr profile image
KocoPr

Thanks for that link. I used to subscribe to petter attia “the drive” this is s great interview. What Dr Rosenberg said on minute 35:30 “my view of the dirty little secret of oncology if the cancer has spread from its local site and cannot be surgically removed then the death rate is 100%.

Except for 4 cancers, but this interview was in Sep 2021, and before the miraculous drug dostarlimab in colon cancer patients.

Chilling but im not giving into that line of thinking

j-o-h-n profile image
j-o-h-n

Center for Cancer Research

National Cancer Institute

Building 10 - Hatfield CRC, Room 3-3940

Bethesda, MD 20892-1201

240-858-3080

SAR@nih.gov

CHIEF

Surgery Branch

SENIOR INVESTIGATOR

HEAD, TUMOR IMMUNOLOGY SECTION

RESEARCH SUMMARY

Dr. Rosenberg pioneered the development of effective immunotherapies and gene therapies for patients with advanced cancers. His studies of the adoptive transfer of genetically modified lymphocytes have resulted in the regression of metastatic cancer in patients with melanoma, sarcomas and lymphomas. His current research is aimed at defining the host immune response of patients to their cancers. These studies emphasize the ability of human lymphocytes to recognize unique cancer antigens and the identification of anti-tumor T cell receptors that can be exploited to develop new cell transfer immunotherapies for the treatment of cancer patients. As Chief, Dr. Rosenberg also oversees the Branch’s extensive clinical program aimed at translating scientific advances into effective immunotherapies for patients with cancer.

Good Luck, Good Health and Good Humor.

j-o-h-n Tuesday 07/12/2022 6:42 PM DST

KocoPr profile image
KocoPr in reply to j-o-h-n

Dr Rosenberg deserves the medal of freedom for his devotion to medicine and for his 47 years of service

j-o-h-n profile image
j-o-h-n in reply to KocoPr

He's got my vote.......

Good Luck, Good Health and Good Humor.

j-o-h-n Wednesday 07/13/2022 5:45 PM DST

You may also like...

Methionine restriction using methionase shows promise for treating advanced prostate cancer

methionine for transmethylation reactions, termed the “Hoffman Effect”. Methionine addiction has...

The Perils and Pitfalls of \"Treating PSA\" in Advanced Prostate Cancer

ability to use PSA to monitor success of our treatments: therapies that select for low PSA sub-types

Starting xgeva next month

cancer cells by red flagging the cells so the immune system can kill them. Dr wants to do monthly...

My PSCA CAR-T Journey

haven't had any Cytokine Release Syndrome ( CRS) reaction yet. In their experience, happens 2-3...

A question about the immune system

I’ve been researching the immune system to see if my hypothesis about using T cells from a patient...